Hans Ehrencrona
51 – 80 of 80
- show: 50
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- « previous
- 1
- 2
- next »
- 2012
-
Mark
Distinct transcriptional control in major immunogenetic subsets of chronic lymphocytic leukemia exhibiting subset-biased global DNA methylation profiles
(
- Contribution to journal › Article
-
Mark
High ERG gene expression is an unfavorable prognostic marker in pediatric acute myeloid leukemia Response
(
- Contribution to journal › Letter
-
Mark
Mantle cell lymphoma displays a homogenous methylation profile: A comparative analysis with chronic lymphocytic leukemia
(
- Contribution to journal › Article
-
Mark
Common Variants at the 19p13.1 and ZNF365 Loci Are Associated with ER Subtypes of Breast Cancer and Ovarian Cancer Risk in BRCA1 and BRCA2 Mutation Carriers.
2012) In Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 21(4). p.645-657(
- Contribution to journal › Article
- 2011
-
Mark
Impact of TP53 mutation and 17p deletion in mantle cell lymphoma
(
- Contribution to journal › Letter
-
Mark
The frequency and prognostic impact of dic(9;20)(p13.2;q11.2) in childhood B-cell precursor acute lymphoblastic leukemia: results from the NOPHO ALL-2000 trial
(
- Contribution to journal › Article
-
Mark
Interplay between BRCA1 and RHAMM Regulates Epithelial Apicobasal Polarization and May Influence Risk of Breast Cancer
(
- Contribution to journal › Article
-
Mark
Common Genetic Variation at BARD1 Is Not Associated with Breast Cancer Risk in BRCA1 or BRCA2 Mutation Carriers
(
- Contribution to journal › Article
-
Mark
Presence of FLT3-ITD and high BAALC expression are independent prognostic markers in childhood acute myeloid leukemia
(
- Contribution to journal › Article
-
Mark
Exploring the link between MORF4L1 and risk of breast cancer
(
- Contribution to journal › Article
-
Mark
Combination of pegylated IFN-alpha 2b with imatinib increases molecular response rates in patients with low- or intermediate-risk chronic myeloid leukemia
(
- Contribution to journal › Article
-
Mark
Evaluation of the XRCC1 gene as a phenotypic modifier in BRCA1/2 mutation carriers. Results from the consortium of investigators of modifiers of BRCA1/BRCA2
(
- Contribution to journal › Article
-
Mark
Bilateral Prophylactic Mastectomy in Swedish Women at High Risk of Breast Cancer: A National Survey.
(
- Contribution to journal › Article
-
Mark
High-resolution genomic screening in mantle cell lymphoma--specific changes correlate with genomic complexity, the proliferation signature and survival.
(
- Contribution to journal › Article
- 2010
-
Mark
A locus on 19p13 modifies risk of breast cancer in BRCA1 mutation carriers and is associated with hormone receptor-negative breast cancer in the general population
(
- Contribution to journal › Article
-
Mark
Genome Wide Array Based Methylation Profiling Reveals Preferential Methylation of Homeobox Transcription Factor Genes In Mantle Cell Lymphoma and Pro Apoptotic Genes In Chronic Lymphocytic Leukemia
(
- Contribution to journal › Published meeting abstract
-
Mark
How to Handle Genetic Information: A Comparison of Attitudes among Patients and the General Population
(
- Contribution to journal › Article
-
Mark
Association of the Variants CASP8 D302H and CASP10 V410I with Breast and Ovarian Cancer Risk in BRCA1 and BRCA2 Mutation Carriers.
2010) In Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 19. p.2859-2868(
- Contribution to journal › Article
-
Mark
Establishment of the first World Health Organization International Genetic Reference Panel for quantitation of BCR-ABL mRNA.
(
- Contribution to journal › Article
- 2009
-
Mark
Common variants in LSP1, 2q35 and 8q24 and breast cancer risk for BRCA1 and BRCA2 mutation carriers
(
- Contribution to journal › Article
-
Mark
Comparison of imatinib 400 mg and 800 mg daily in the front-line treatment of high-risk, Philadelphia-positive chronic myeloid leukemia: a European LeukemiaNet Study.
(
- Contribution to journal › Article
-
Mark
Clinical and cytogenetic features of a population-based consecutive series of 285 pediatric T-cell acute lymphoblastic leukemias: Rare T-cell receptor gene rearrangements are associated with poor outcome.
(
- Contribution to journal › Article
- 2008
-
Mark
U-2973, a novel B-cell line established from a patient with a mature B-cell leukemia displaying concurrent t(14;18) and MYC translocation to a non-IG gene partner.
(
- Contribution to journal › Article
- 2004
-
Mark
A specific requirement for PDGF-C in palate formation and PDGFR-alpha signaling.
(
- Contribution to journal › Article
- 2002
-
Mark
PDGF-A/PDGF alpha-receptor signaling is required for lung growth and the formation of alveoli but not for early lung branching morphogenesis.
(
- Contribution to journal › Article
- 2000
-
Mark
PDGF-C is a new protease-activated ligand for the PDGF alpha-receptor.
(
- Contribution to journal › Article
- 1999
-
Mark
PDGFB regulates the development of the labyrinthine layer of the mouse fetal placenta.
(
- Contribution to journal › Article
-
Mark
Defective oligodendrocyte development and severe hypomyelination in PDGF-A knockout mice.
(
- Contribution to journal › Article
-
Mark
Role of platelet-derived growth factors in angiogenesis and alveogenesis.
(
- Contribution to journal › Scientific review
- 1996
-
Mark
PDGF-A signaling is a critical event in lung alveolar myofibroblast development and alveogenesis.
(
- Contribution to journal › Article
- « previous
- 1
- 2
- next »